Skye Bioscience, Inc. Common Stock Share Price

NASDAQ: SKYE

Mid Cap

$3.92

+0.01

(+0.38%)

as on September 19, 2025 at 1:29 am IST

$₹

Skye Bioscience, Inc. Common Stock Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$3.85
Day's Price Range
$4.19
$3.92
1.79%
Downside
6.89%
Upside
52 Week's Low
52 Week's High
$1.14
52-Week Price Range
$5.96
$3.92
70.92%
Downside
52.04%
Upside

Skye Bioscience, Inc. Common Stock share price movements today

Previous Close: $3.91
Open: $3.98
Volume: 551.9K
Day's Low - High: $3.85 - $4.19
52 Week Low - High: $1.14 - $5.96

Skye Bioscience, Inc. Common Stock Historical Returns

1 Month Return: + 15.34 %
3 Month Return: + 82.71 %
1 Year Return: -25.38 %
3 Year Return: -37.19 %
5 Year Return: 0 %

Skye Bioscience, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Skye Bioscience, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$119.6M

EPS (TTM)

-1.3433

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

79796800.00%

Skye Bioscience, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Skye Bioscience, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Skye Bioscience, Inc. Common Stock	NA	$119.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Skye Bioscience, Inc. Common Stock Stock including INR - Dollar returns

The Skye Bioscience, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Skye Bioscience, Inc. Common Stock investment value today

Current value as on today

₹79,762

Returns

₹20,238

(-20.24%)

Returns from Skye Bioscience, Inc. Common Stock Stock

₹25,191 (-25.19%)

Dollar Returns*

₹4,953 (+4.95%)

Skye Bioscience, Inc. Common Stock Stock's Interest Amongst Investors

Search interest for Skye Bioscience, Inc. Common Stock Stock has increased by 164% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:164% versus previous 30 day period

Skye Bioscience, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-2	-24	-4	-6	-8	-9	-10	-11	-18
EBITDA	-5	-2	-24	-3	-4	-7	-3	-9	-10	-17
Interest Expense	0	0	0	0	0	0	0	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-3	-24	-4	-5	-7	-3	-9	-11	-17
Income Tax Expense	0	0	0	0	0	0	-	-	0	0
Net Income	-5	-3	-24	-4	-5	-7	-3	-9	-11	-17
Net Profit Margin	0.00%	0.00%	0.00%	-2705.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-3	-4	-6	-6	-7	-12	-13	-36
EBITDA	-3	-4	2	-5	-7	-18	-36	-25
Interest Expense	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-3	-19	1	-6	-8	-19	-37	-26
Income Tax Expense	0	0	0	0	0	0	0	0
Net Income	-3	-19	1	-6	-8	-19	-37	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-24	-4	-5	-7	-3	-9	-11	11,074
Operating Cash Flow	-1	-4	-3	-4	-7	-5	-8	-9,185	-10
Investing Cash Flow	1	1	0	1	0	-1	0	-12,808	-11
Financing Cash Flow	0	16	0	85	-2	-	0	-	0
Change in Cash	-2	13	-3	82	-9	-6	-8	-21,994	-22

Skye Bioscience, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-3	-19	1	-6	-8	-19	-37	-26
Operating Cash Flow	-3	-3	-3	-6	-6	-6	-12	-13	-25
Investing Cash Flow	0	0	0	0	0	0	5	6	0
Financing Cash Flow	0	3	5	6	6	13	0	16	83
Change in Cash	-3	0	1	0	0	6	-7	9	58

Insights on Skye Bioscience, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 67.3% return, outperforming this stock by 96.1%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 114.6% return, outperforming this stock by 149.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, SKYE stock has moved down by -8.0%

About Skye Bioscience, Inc. Common Stock

Skye Bioscience, Inc. is a clinical-stage biotechnology company. The Company is focused on development of next-generation molecules that modulate G-protein coupled receptors to treat obesity, overweight, and related conditions. The Company’s lead candidate, nimacimab, is a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1). The Company is also focused on its Phase IIa clinical trial, CBeyond, for nimacimab. The CBeyond clinical trial includes approximately 136 patients, 16 clinical trial sites and a combination arm with a GLP-1 receptor agonist to assess differences in weight loss, body composition, and other attributes. The CB1 receptor is one of the receptors in the endocannabinoid system (ECS) and plays a significant role both in the central nervous system (CNS) and peripheral tissues. The Company's Phase II study in obesity for nimacimab, is a negative allosteric modulating antibody that peripherally inhibits CB1.

Organisation	Skye Bioscience, Inc. Common Stock
Headquarters	11250 El Camino Real, San Diego, CA, United States, 92130
CEO	Mr. Punit S. Dhillon B.A.
E-voting on shares	Click here to vote

Key Management of Skye Bioscience, Inc. Common Stock

Name	Title
Mr. Punit S. Dhillon B.A.	President, CEO, Secretary & Director
Ms. Kaitlyn Melanie Arsenault CPA	Chief Financial Officer
Mr. Tu Diep M.Sc.	Chief Operating Officer
Dr. Christopher G. Twitty Ph.D.	Chief Scientific Officer
Mr. Brennen Brodersen J.D.	General Counsel
Dr. Puneet S. Arora FACE, M.D., M.S.	Chief Medical Officer

FAQs

What is Skye Bioscience, Inc. Common Stock share price today?

Skye Bioscience, Inc. Common Stock share price today is $3.92 as on September 19, 2025 at 1:29 am IST at the close of the market. Skye Bioscience, Inc. Common Stock share today touched a day high of $4.19 and a low of $3.85.

What is the 52 week high and 52 week low for Skye Bioscience, Inc. Common Stock share?

Skye Bioscience, Inc. Common Stock share touched a 52 week high of $5.96 on November 8, 2024 and a 52 week low of $1.14 on April 8, 2025. Skye Bioscience, Inc. Common Stock stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $3.92,which is 34.23% down from its 52 week high and 243.86% up from its 52 week low.

What is Skye Bioscience, Inc. Common Stock's market capitalisation today?

Skye Bioscience, Inc. Common Stock market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Skye Bioscience, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Skye Bioscience, Inc. Common Stock Shares that will get you 0.3827 shares as per Skye Bioscience, Inc. Common Stock share price of $3.92 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

Indian investors can start investing in Skye Bioscience, Inc. Common Stock (SKYE) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 6:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Skye Bioscience, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 6:42 am IST). Based on Skye Bioscience, Inc. Common Stock share’s latest price of $3.92 as on September 19, 2025 at 1:29 am IST, you will get 2.5510 shares of Skye Bioscience, Inc. Common Stock. Learn more about fractional shares .